Title	Publication Date	Language	Citations
Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma	2024/01/12	English
Interferon therapy improves survival in patients with hepatitis B virus-related hepatocellular carcinoma after curative surgery: a meta-analysis	2024/01/02	English
Connection between HPS and ACLF: a solution of chaos?	2021/10/01	English
Response to “Iodized Oil CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Within Milan Criteria”	2022/01/28	English
SARS-Cov-2 (human) and COVID-19: Primer 2020	2020/04/24	English
Evidence of nucleos(t)ide analogue (NUC) therapy in HBV DNA negative decompensated cirrhosis	2021/07/16	English
Is tenofovir more effective than entecavir to prevent hepatocellular carcinoma? The controversy goes on	2020/08/13	English
The main reasons for finite Nuc therapy in HBeAg-negative chronic hepatitis B patients	2021/04/01	English
Human fascioliasis presenting as liver abscess: clinical characteristics and management	2021/04/17	English
Biomarkers of endothelial dysfunction in alcoholic hepatitis	2021/05/27	English
The prevalence of occult HBV infection in immunized children with HBs Ag positive parents: a hospital based analysis	2021/02/18	English
Author’s reply to “Thromboelastometry in patients with advanced chronic liver disease: a complex interplay”	2021/02/17	English
Thromboelastometry in patients with advanced chronic liver disease: a complex interplay	2021/01/29	English
New treatment-induced adverse effects we need to learn as modern hepatologists	2019/04/23	English
Hepatitis B-positive health-care workers: why they should not switch to non-exposure-prone jobs	2018/10/11	English
Extracorporeal devices for treatment of refractory pruritus in cholestatic liver disease	2017/06/06	English
Spontaneous bacteremia and spontaneous bacterial peritonitis in cirrhosis: two infections but similar outcomes?	2018/03/01	English
Autoimmune liver disease in Asian children	2015/01/06	English
Abstracts—HCV infection and disease, APASL STC Conference, Dec 18–20, New Delhi	2016/01/01	English
Viral factors and outcome of chronic hepatitis B revisited	2013/09/11	English
Speckle tracking echocardiography in cirrhosis: is it ready for prime time?	2014/01/01	English
Stopping oral antiviral treatment to cure chronic hepatitis B, is it in sight?	2020/04/17	English
New generation cancer therapy: right direction for sure with some uncertainty	2018/11/07	English
Tenofovir Alafenamide use in pregnant women with chronic hepatitis B virus infection: more data needed	2022/07/06	English
HBV in pregnancy: time to consider tenofovir alafenamide (TAF)	2022/07/06	English
The bidirectional relationship between nonalcoholic fatty liver disease and sarcopenia	2022/03/28	English
No additive effects of peginterferon on the short-term improvement of liver histology by entecavir monotherapy in chronic hepatitis B patients	2021/04/26	English
Prognosis prediction or treatment allocation?	2021/05/09	English
Lusutrombopag for thrombocytopenia in Chinese patients with chronic liver disease undergoing invasive procedures	2022/10/18	English
Is lean non-alcoholic fatty liver disease a distinct entity?	2022/03/24	English